Amazon Q1 2026 Demand Trends and Backlog Insights for AWS AI Revenue

Growth drivers for Ecolab’s High Tech and Life Sciences segments in 2026 (per Q1 2026 remarks)

1) High Tech: why it’s growing and what’s driving the acceleration in 2026

A. Strong organic demand tied to digital adoption and the “AI wave”

• Ecolab said Global High Tech and Digital grew more than 20% and that this was driven by strong demand tied to digital adoption and the ongoing AI wave. ¹

B. AI-driven need for circular water management and high-performance cooling

• Management emphasized that AI is driving significant new demand for circular water management and high-performance cooling within Global High Tech. ²
• Ecolab further connected AI buildouts to customer priorities: as AI accelerates digital infrastructure, customers are prioritizing uptime, cooling performance, and reliable water management, alongside massive increases in compute power with lower energy use and a near net-zero water footprint. ²

C. Technology stack expansion from OVIVO + (pending) CoolIT, supporting microelectronics + data centers

• Ecolab described building a combined $1.5 billion “powerhouse” by bringing CoolIT and OVIVO together with its Global High Tech water business, aimed at fueling next-phase growth and margin expansion. ²
• In the near-term 2026 demand capture, Ecolab stated that CoolIT’s Q1 2026 sales were growing well ahead of 30%+ discussed on the acquisition call, and said demand for leading liquid cooling technologies is rapidly accelerating. ³
• Management also said Global High Tech is expected to become the strongest growth engine for the near-to-long-term future. ⁴

D. Recurring elements: “direct-to-chip” cooling creates an inherently recurring refresh cycle

• Ecolab described the operational reality behind recurring demand: with new generations of chips, customers change systems for direct-to-chip cooling (cold plates, coolant, and potentially CDUs), and Ecolab noted that the offering is inherently recurring. ⁵
• The acquisition rationale reinforced this same outcome focus: for data centers, Ecolab said it offers higher uptime at lower water usage and better power performance, and that customers are seeking direct-to-chip cooling to enable advanced chips. ²

---

2) Life Sciences: why it’s growing in 2026 and what’s driving the momentum

A. Life Sciences is accelerating to double-digit growth (11% in Q1)

• Ecolab stated Life Sciences accelerated to 11% growth in the first quarter, and described it as part of continued strengthening momentum. ¹
• Management framed Life Sciences as a business it is building into a double-digit growth business, with investment behind the segment. ⁶

B. Bioprocessing is the key engine—sales more than doubled

• Ecolab explicitly identified bioprocessing as the driver: Life Sciences’ growth was led by bioprocessing, where sales more than doubled. ¹
• Management reiterated bioprocessing momentum, stating that its bioprocessing business grew north of 100% in the first quarter. ⁶

C. Capacity buildout and operational readiness are enabling growth

• Ecolab credited internal execution and capacity readiness for the Life Sciences performance: management said it was pleased with the team for getting capacity, quality, systems, and platform R&D together to reach planned performance, resulting in 11% in Q1. ⁶
• Management also highlighted that growth depends on more capacity, calling it a “good problem to have,” and pointed to a plant to open in the second half of the year to unleash additional capacity. ⁶

D. Sustained double-digit momentum and margin expansion targeting

• For 2026, Ecolab guided that it expects Life Sciences’ growth to continue its double-digit momentum and that it expects operating income margin to expand toward a 30% target over the next few years. ¹
• Management also indicated that investments are central to sustaining the trajectory and that it expects to stay in a double-digit growth business while building leverage over time. ⁶

---

Bottom line (2026 drivers, summarized)

• High Tech (Global High Tech & Digital): growth is driven primarily by AI- and digital-adoption-led demand for high-performance cooling and circular water management, reinforced by the segment’s technology platform (including OVIVO and CoolIT, with CoolIT Q1 2026 sales growing well ahead of 30%+), and supported by recurring “direct-to-chip” cooling refresh cycles. ¹³²⁴⁵
• Life Sciences: growth is driven mainly by bioprocessing, where sales more than doubled (and bioprocessing grew north of 100% in Q1), with additional support from capacity expansion, execution readiness (capacity/quality/systems/platform R&D), and management’s expectation of continued double-digit growth momentum. ¹⁶